From: Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer
Variable | ORa | 95% CIa | Adjusted Pa |
---|---|---|---|
Age at diagnosis (years) | |||
<50 | Referent | ||
50 to 69 | 0.701 | 0.407 to 1.207 | 0.200 |
≥70 | 0.337 | 0.169 to 0.674 | 0.002 |
Comorbidities | |||
None | Referent | ||
One or more | 1.075 | 0.813 to 1.420 | 0.613 |
Menopausal status | |||
Premenopause | Referent | ||
Menopause | 1.319 | 0.773 to 2.249 | 0.310 |
Residential status | |||
Rural | Referent | ||
Urban | 1.265 | 0.979 to 1.633 | 0.072 |
Tumor size | |||
≤2 | Referent | ||
>2 | 1.266 | 0.888 to 1.804 | 0.192 |
Lymph node metastasis | |||
Negative | Referent | ||
Positive | 1.933 | 1.508 to 2.477 | <0.001 |
Distant metastasis | |||
Negative | Referent | ||
Positive | 2.639 | 0.326 to 21.335 | 0.363 |
Hormone-receptor status | |||
ER- and PR- | Referent | ||
ER + and/or PR+ | 1.392 | 0.986 to 1.964 | 0.060 |